Crosslinked Nucleic Acid Molecule for Gene Silencing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current RNA interference (RNAi) methods, such as siRNA, face challenges with strand bias and off-target effects, limiting their gene expression suppression efficacy and safety.

Innovation Solution

A novel single-stranded nucleic acid molecule is developed where the antisense and sense strands are linked via a non-nucleotide linker, specifically through cross-linking between the 2′ and 2′ sugar moieties of the nucleosides, creating a molecule with gene expression-suppressing activity comparable to siRNA while minimizing off-target effects.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional siRNA is used for gene expression suppression, then gene silencing activity is achieved, but off-target effects and strand bias occur

Engineering Contradiction:
Improvegene silencing activityVSAvoidoff-target effects
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The invention extracts and eliminates the problematic sense strand from the conventional siRNA double-stranded structure. By using a single-stranded RNA molecule that functions independently without requiring a separate sense strand, the off-target effects caused by sense strand incorporation into RISC are removed while maintaining the antisense-mediated gene silencing activity.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention introduces a modified backbone structure with phosphoramidate linkages as an intermediary between the ribose units. This chemical modification serves as a mediator that prevents recognition by cellular nucleases while maintaining the molecule's ability to bind to AGO protein and function in RNAi, thereby improving stability without compromising activity.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If conventional siRNA design follows strand bias rules, then antisense strand incorporation is optimized, but sequence design flexibility is reduced

Engineering Contradiction:
Improveantisense strand incorporation efficiencyVSAvoidsequence design flexibility
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The invention segments the conventional double-stranded siRNA into a single functional antisense strand that operates independently. This segmentation eliminates the need to design complementary sense and antisense pairs while satisfying strand bias constraints, allowing direct design of antisense sequences against any target mRNA without worrying about sense strand pairing requirements.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention inverts the conventional approach by making the antisense strand the sole functional component rather than one of two equal strands. This inversion allows the antisense sequence to be designed freely against any target without being constrained by the need to form a stable double-stranded structure with a sense strand, thereby reversing the traditional design limitations.

Inventive Principle:
Principle #13The other way round (Inversion)

3Reliability

If conventional siRNA with phosphodiester backbone is used, then gene silencing function is achieved, but nuclease degradation occurs

Engineering Contradiction:
Improvegene silencing functionVSAvoidmolecule stability
Core Design Contradiction:
ReliabilityVSDuration of action of stationary object

Solution Approach 1:

The invention changes the chemical parameter of the backbone linkage from phosphodiester to phosphoramidate. This parameter change increases the molecule's resistance to nuclease degradation by altering the chemical bond that nucleases typically cleave, thereby extending the half-life and duration of action of the siRNA molecule while preserving its gene silencing function.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The crosslinked nucleic acid molecule achieves gene expression suppression with efficiency equivalent to or higher than siRNA, reduces off-target effects, and operates outside the constraints of strand bias, allowing for a broader range of targetable sequences.

Implementation Method 1

cross-linking between the 2′ and 2′ sugar moieties of the nucleosides

Methodology Applied
Scientific EffectCross-linking: Chemical Bonding

Implementation Method 2

one of which is a sequence complementary to the target nucleic acid sequence, and the other is a sequence complementary thereto

Methodology Applied
Scientific EffectBase pairing: Chemical Bonding

Data Source

PatentUS20230357767A1Novel nucleic acid molecule inhibiting expression of target gene
Publication Date: 2023.11.09 TSUMUGI KOSAN KK
  • US20230357767A1 patent drawing
  • US20230357767A1 patent drawing
  • US20230357767A1 patent drawing

AI summary

The present invention aims to provide a new nucleic acid molecule for suppressing expression of the target gene, which (1) has a gene expression suppressing activity equivalent to or higher than that of siRNA, (2) shows no off-target effect of the sense strand, and (3) makes it possible to design a wider range of antisense strand sequences (extends the range of targetable sequences). Since the nucleic acid molecule of the following formula:wherein each symbol is as defined in the DESCRIPTION, has the superior properties of the above-mentioned (1) to (3), it is extremely useful as a novel gene expression inhibitor that replaces conventional siRNA.